Journal ArticleOPEN ACCESS

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy

Annals of Oncology (2015) 26(2) 307-313
DOI: 10.1093/annonc/mdu528
47Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We collected information on 904 consecutive breast cancer patients treated with neoadjuvant chemotherapy at the European Institute of Oncology, Milan, Italy, between 1999 and 2011. The decrease of PgR and Ki-67 expression after preoperative chemotherapy has a prognostic role in breast cancer patients with residual disease.

Author supplied keywords

Cite

CITATION STYLE

APA

Montagna, E., Bagnardi, V., Viale, G., Rotmensz, N., Sporchia, A., Cancello, G., … Colleoni, M. (2015). Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy. Annals of Oncology, 26(2), 307–313. https://doi.org/10.1093/annonc/mdu528

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free